New ultrasound technique could spot brain injury in preterm babies sooner
NCT ID NCT07358819
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test whether a new 3D ultrasound method, combined with artificial intelligence, can better detect early brain injury in very preterm infants (born before 30 weeks). Researchers will scan 360 babies at several time points and compare the results with brain MRIs and developmental tests at age 2. The goal is to find simple bedside markers that predict neurodevelopmental disorders, helping doctors start supportive therapies earlier.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a bedside tool that helps doctors predict neurodevelopmental problems earlier in preterm infants, enabling timely interventions.
- What could go wrong
- This is an observational study, not a treatment trial. The new imaging method may not prove more accurate than existing approaches, and results may not change clinical practice immediately.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 360 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2031
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
23 to 35 weeks
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Very preterm infants delivered (either inborn or outborn) between 23+0 and 29+6 weeks of gestation * Informed written consent of the holders of parental authority. Exclusion Criteria: * Admission for palliative care * Chromosomal aberrations and major malformations evidenced after birth Major malformations * Chromosomal aberrations * No social security coverage
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Very preterm infants born < 30 weeks of gestation are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hôpital Cochin Port-Royal, APHP Centre
Paris, Île-de-France Region, 75014, France